2023 Notice of the Annual General Meeting
Tuesday, 14 November 2023
LEI: 213800J4UVB5OWG8VX82
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Availability of 2023 Notice of the Annual General Meeting
The Notice of the 2023 Annual General Meeting is now available to view at www.dechra.com.
The following documents will be mailed today to registered shareholders of the Company who have elected to receive postal copies:
· Notice of the 2023 Annual General Meeting; and
· Proxy Form for the 2023 Annual General Meeting.
In accordance with Listing Rule 9.6.1 a copy of each of these documents will be submitted to the National Storage Mechanism and will be available for viewing shortly after posting.
The Annual General Meeting is scheduled to be held on 13 December 2023 at 11.00am.
For further information, please contact:
Melanie Hall, Company Secretary
Dechra Pharmaceuticals PLC
Telephone number: +44 (0) 1606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, marketing and sales of high quality products exclusively for veterinarians worldwide. For more information please visit: www.dechra.com.
Trademarks
Trademarks appear throughout this document in italics. Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 25 minutes ago Rome Resources
- 1 hour ago Bezant Resources
- 1 hour ago Cranswick
- 2 days ago IntegraFin Holding
- 2 days ago Spirent Communications